Search for: "Novo Nordisk, Inc." Results 1 - 20 of 134
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Dec 2023, 6:00 am by Levin Papantonio
The JPML issued a Transfer Order to centralize lawsuits alleging that drug manufacturers and pharmacy benefit manufacturers (PBMs) engaged in an unfair and deceptive conspiracy to orchestrate an insulin pricing scheme.Defendants in these actions include insulin manufacturers Eli Lilly and Company, Novo Nordisk, Inc., and Sanofi-Aventis U.S. [read post]
7 Aug 2023, 6:01 am by Levin Papantonio
Martinotti, who presides over the three most advanced actions related to the alleged insulin pricing scheme.The newly formed Insulin Price-Fixing MDL (No. 3080) will serve to "avoid duplication of discovery, prevent inconsistent pretrial rulings, and to conserve the resources of the parties, their counsel and the judiciary," the panel explains on its website.Defendants in these actions include insulin manufacturers Eli Lilly and Company, Novo Nordisk, Inc., and… [read post]
28 Feb 2023, 12:22 pm by Kevin LaCroix
During 2022, the Bernstein Litowitz firm was lead or co-lead counsel in cases with settlements over $100 million: the Luckin Coffee settlement ($175 million) and the Novo Nordisk settlement ($100 million). [read post]
9 Jan 2023, 9:01 pm by renholding
Walgreens After more than seven years of litigation, Walgreens, Inc. [read post]
5 Jan 2023, 2:22 pm by Kevin LaCroix
Jeff LubitzJarett SenaIn the following guest post, Jeff Lubitz, Managing Director, ISS Securities Class Action Services, and Jarett Sena, Director of Litigation Analysis, ISS Securities Class Action Services, take a detailed look at the largest securities class action settlements of 2022, and in particular at the largest 10 U.S. securities class action settlements during the year as well as the largest non-U.S. settlements. [read post]
18 Jul 2022, 2:46 pm by Kevin LaCroix
Regular readers of this blog know my view that the  rise of collective investor actions outside the United States is one of the most important developments in the world of directors’ and officers’ liability in recent years. [read post]
9 Mar 2022, 2:06 pm by Kevin LaCroix
  In addition to these settlements that have final court approval hearings already scheduled in 2022, there are a number of other large pending settlements that do not yet have court hearings scheduled, including the $809.5 million Twitter settlement; the $100 million Novo Nordisk settlement; and the $100 million NCI Building Systems case. [read post]
25 Jan 2022, 3:11 pm by Kevin LaCroix
  There have already been several significant settlements that appear positioned for court approval in 2022, including Twitter ($809.5 million); Teva Pharmaceutical Industries ($420 million); Luckin Coffee ($175 million); Granite Construction ($129 million); Novo Nordisk A/S ($100 million); Stamps.com ($100 million) and NCI Building Systems, Inc. ($100 million). [read post]
4 Nov 2021, 4:38 pm by Ross M. Wolfe
Description/Success Story/Testimonial: Represented whistleblower in an action under False Claims Act alleging off-label marketing and REMS violations, resulting in a $58 million settlement. [read post]
27 Jul 2020, 4:51 pm by James Hays and Jamie Moelis*
Novo Nordisk, the First Circuit affirmed a district court judgment that prevented pharmaceutical company Novo Nordisk Inc. from enforcing a confidentiality and non-compete agreement that it had entered into with employee Thomas Russomano, who was briefly laid off and rehired before leaving the company for a competing company. [read post]
21 May 2020, 7:18 am by Mark G. McCreary
Moderator: Susan VonNessen-Scanlin ’87 FCN, CEO Rutgers Community Health Center, Rutgers University Panel: Dan Kelley ’01 MS, CTO, Keriton Doug Langa P ’21, ’23, President, Novo Nordisk, Inc. [read post]
17 Mar 2020, 1:32 pm by Noble McIntyre
Lidocaine HCl Topical Solution 4%, 50ml, has been recalled by Teligent Pharma, Inc. due to super potency. [read post]
4 Nov 2019, 5:01 am by Eugene Volokh
Indeed, there is "a presumption that 'all materials and judicial proceedings are matters of public record and shall not be sealed.' " Novo Nordisk A/S v. [read post]
1 Dec 2017, 11:35 am by Nate Nead
Big pharma players such as Eli Lilly, Novo Nordisk and Allergan are committed to voluntary price restraints, while companies such as Novartis and Roche are in favor of value-based pricing. [read post]